Dublin, Oct. 17, 2017 -- The "Biologic and Medical Imaging Reagents: Global Markets" report has been added to Research and Markets' offering.
The scope of the study includes the biological imaging reagents that are already commercialized or likely to be commercialized within the next five years. Fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); fluorescent proteins; contrast reagents for MRI, X-ray and ultrasound; and imaging radiopharmaceuticals are studied. Both the in vivo and in vitro market segments are included. Each technology is analyzed to determine its market status, impact on future market segments and forecast growth from 2017 through 2022. Technology status and market driving forces are also discussed.
Imaging reagent producers and the industry structure are examined in specialized segments of the industry. We also review industry alliances and acquisitions, and the use of biological imaging reagents in key diagnostics and research and development (R&D) tools platforms, including microarrays, lab-on-a-chip devices, DNA sequencing, PCR and cellular analysis. The markets for novel biological imaging reagent applications, including targeted multifunctional and hybrid therapeutic reagents, are analyzed, and the main companies in these fields are highlighted.
Report Includes
- 32 data tables and 76 additional tables
- An overview of the global markets for biologic and medical imaging reagents
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- A comprehensive analysis of imaging techniques as an important tool in medical diagnostic procedures
- Coverage of current and future strategies within the medical imaging technology market
- A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods
- A detailed analysis of the industry structure
- Profiles of major players in the industry
Topics Covered in this Report Include:
- Fluorescent dyes and probes.
- Fluorescent proteins.
- Nanoparticles, including quantum dots.
- Supermolecules.
- Imaging radiopharmaceuticals.
- Contrast reagents for X-ray/CT, MRI and ultrasound.
Topics not Covered in this Report Include:
- Nanotechnology.
- Drug delivery.
- Coatings.
- Supramolecular chemistry.
- Imaging instruments and software.
Key Topics Covered:
1: Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Contribution of the Study and for Whom
- Scope of Report
- Methodology
- Information Sources
2: Executive Summary
3: Overview
- Introduction
- Market Potential
- Industry Growth Driving Forces
- Industry Growth Drivers
4: Biological Imaging Technologies
- Imaging Reagent Types
- In Vivo Imaging Modalities
- Trends in In Vivo Imaging
- Biological Imaging Reagents Technologies
- Emerging Classes of Imaging Reagents
- Comparison of Imaging Reagent Technology Platforms
5: Biological Imaging Reagents Applications
- Overview
6: Biological Imaging Reagents Industry Structure
- Overview
- Research and Development
- Drug Discovery and Development
- Diagnostics
7: Competitive Landscape
- Innovation Within the Imaging Reagent Industry
- Strategic Alliances
- Industry Acquisitions
- Table 54 : Recent FDA Approvals in the Biological Imaging Reagent Industry
8: Biological Imaging Reagents Markets
- Growth Driving Forces
9: Patent Status
10: Company Profiles
- ABT Molecular Imaging Inc.
- ABX Advanced Biochemical Compounds Gmbh
- Active Motif Chromeon Gmbh
- Acusphere Inc.
- Advanced Accelerator Applications Sa
- Advanced Proteome Therapeutics Inc.
- Advanced Research Technologies Inc.
- Affibody Ab
- Agenix Ltd.
- Alseres Pharmaceuticals Inc.
- Alzhyme Pty Ltd.
- Amag Pharmaceuticals Inc.
- American Dye Source Inc.
- American Elements
- Anaspec Inc.
- Anticancer Inc.
- Aposense
- Areva
- Astellas Pharma Inc.
- Astrazeneca Ltd.
- Atreus Pharmaceuticals Corp.
- Atto-Tec Gmbh
- Axxam Spa
- Bayer Healthcare Ag
- BBI International
- BD
- Beckman Coulter Inc.
- Betaplus Radiopharmaceutials Llc
- Bioforce Nanosciences Holdings Inc.
- Biosceptre International Ltd.
- Biosearch Technologies Inc.
- Biotium Inc.
- Biovision Inc.
- Bracco Imaging Spa
- Capsulution Pharma Ag
- Cardinal Health
- Carestream Health Inc.
- Cellcyte Genetics
- Cellpoint Llc.
- Chematech Sas
- Chemicell Gmbh
- China Medical Technologies Inc.
- Chromotek Gmbh
- Cisbio Bioassays
- Covalys Biosciences Ag
- Covidien Plc
- Cytodiagnostics
- Daiichi Sankyo Co. Ltd.
- Dendritech Inc.
- Denovo Biolabels Gmbh
- Ebioscience Inc.
- Eckert & Ziegler Ag
- Eli Lilly And Co.
- Erigal Ltd.
- Estech Pharma Co. Ltd.
- Evident Technologies
- Evrogen
- Ferropharm Gmbh
- Fluoptics
- Fluoropharma Inc.
- Fuji Pharma Co. Ltd.
- Ge Healthcare
- Genisphere Llc
- Guerbet
- Iason Gmbh
- Imaginab Inc.
- Immunomedics Inc.
- Indec Biosystems
- Innoprot
- Invisage Inc.
- Ipsen Group
- Iso-Tex Diagnostics Inc.
- Jazz Pharmaceuticals Plc
- J.B. Chemicals & Pharmaceuticals Ltd.
- Johnson & Johnson
- Jubilant Life Sciences Ltd.
- Kereos Inc.
- Kpl Inc.
- Lab21 Ltd.
- Laboratoires Cyclopharma
- Lantheus Medical Imaging
- Life Technologies Inc.
- Lumiphore Inc.
- Luna Nanoworks
- Marinpharm Gmbh
- Marval Biosciences Inc.
- MBL International
- Medi Radiopharma Ltd.
- Mellitech Sas
- Mobiotec Gmbh
- Molecular Insight Pharmaceuticals
- Molecular Targeting Technologies Inc.
- Nanoaxis Llc
- Nanoco Technologies Ltd.
- Nano-H Sas
- Nanoprobes Inc.
- Nanoscan Imaging Llc
- Nanospectra Biosciences
- Nanosphere Inc.
- Navidea Biopharmaceuticals
- Nn-Labs Llc
- Nuview Life Sciences
- Ocean Nanotech Llc
- Octreopharm Sciences Gmbh
- Oxford Contrast Molecular Diagnostics
- Oxonica Inc.
- Perkinelmer Inc.
- Pharmalucence Inc.
- Philips Healthcare
- Photocure Asa
- Piramal Healthcare Ltd.
- Principio Inc.
- Promega Corp.
- Quantum Materials Corp.
- Rapidscan Pharma Solutions Inc.
- Reade Advanced Materials
- Siemens Ag
- Sirigen Ltd.
- Signalomics Gmbh
- Sofie Biosciences
- Spago Nanomedical
- Taejoon Pharma Co. Ltd.
- Takara Bio Inc.
- Targeson Inc.
- Theragnostic Technologies Inc.
- Thermo Fisher Scientific
- Tk-Signal Ltd.
- Top SRL
- Wilex Ag
For more information about this report visit https://www.researchandmarkets.com/research/lj4pm4/biologic_and
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Imaging


Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



